Citadel Advisors - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 178 filers reported holding BLUEBIRD BIO INC in Q1 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$3,656,132
+40.2%
1,202,675
+51.7%
0.00%
Q2 2023$2,608,095
-67.8%
792,734
-68.9%
0.00%
-100.0%
Q1 2023$8,097,775
+85.2%
2,546,470
+302.9%
0.00%
Q4 2022$4,373,467
-51.2%
632,004
-55.4%
0.00%
-100.0%
Q3 2022$8,971,000
+56.2%
1,417,247
+2.2%
0.00%0.0%
Q2 2022$5,744,000
+254.8%
1,387,282
+315.4%
0.00%
Q1 2022$1,619,000
-50.8%
333,925
+1.4%
0.00%
Q4 2021$3,291,000
+7.1%
329,435
+104.9%
0.00%
Q3 2021$3,074,000
-60.5%
160,813
-33.9%
0.00%
-100.0%
Q2 2021$7,785,000
-7.7%
243,447
-12.9%
0.00%
+50.0%
Q1 2021$8,430,000
-23.5%
279,590
+9.8%
0.00%
-33.3%
Q4 2020$11,023,000
-51.9%
254,734
-40.0%
0.00%
-50.0%
Q3 2020$22,904,000
+34.3%
424,546
+51.9%
0.01%0.0%
Q2 2020$17,060,000
-69.4%
279,477
-77.0%
0.01%
-76.0%
Q1 2020$55,802,000
-34.5%
1,214,151
+25.0%
0.02%
-32.4%
Q4 2019$85,245,000
+145.7%
971,454
+157.1%
0.04%
+131.2%
Q3 2019$34,691,000
+32.7%
377,809
+83.9%
0.02%
+33.3%
Q2 2019$26,136,000
+12.1%
205,476
+38.7%
0.01%0.0%
Q1 2019$23,305,000
-7.0%
148,131
-41.3%
0.01%
-14.3%
Q4 2018$25,048,000
-34.9%
252,500
-4.1%
0.01%
-17.6%
Q3 2018$38,453,000
-49.7%
263,379
-45.9%
0.02%
-55.3%
Q2 2018$76,461,000
+59.5%
487,167
+73.6%
0.04%
+40.7%
Q1 2018$47,927,000
+2.5%
280,682
+7.0%
0.03%
-6.9%
Q4 2017$46,740,000
+108.6%
262,434
+60.9%
0.03%
+61.1%
Q3 2017$22,404,000
+38.7%
163,108
+6.0%
0.02%
+38.5%
Q2 2017$16,158,000
+176.2%
153,810
+139.0%
0.01%
+116.7%
Q1 2017$5,851,000
+85.6%
64,355
+25.9%
0.01%
+50.0%
Q4 2016$3,153,000
-55.2%
51,100
-50.8%
0.00%
-42.9%
Q3 2016$7,041,000
+497.7%
103,891
+274.7%
0.01%
+600.0%
Q1 2016$1,178,000
-17.0%
27,728
+25.4%
0.00%
-50.0%
Q4 2015$1,420,000
-77.6%
22,114
-70.2%
0.00%
-66.7%
Q3 2015$6,350,000
+390.0%
74,227
+864.1%
0.01%
+500.0%
Q2 2015$1,296,000
-94.4%
7,699
-96.0%
0.00%
-95.5%
Q1 2015$23,223,000
+33.0%
192,286
+1.0%
0.02%
+29.4%
Q4 2014$17,455,000
+535.7%
190,301
+148.6%
0.02%
+466.7%
Q3 2014$2,746,000
+1049.0%
76,535
+1139.8%
0.00%
Q2 2014$239,000
-80.8%
6,173
-87.7%
0.00%
-100.0%
Q2 2013$1,248,00049,9910.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders